Day: January 3, 2024

Nuclear Fuels Announces Upsize of Bought Deal Private Placement Financing to C$6.4 Million

Nuclear Fuels Announces Upsize of Bought Deal Private Placement Financing to C$6.4 Million

Not for distribution in the United States or to U.S. newswire services VANCOUVER, British Columbia, Jan. 03, 2024 (GLOBE NEWSWIRE) — Nuclear Fuels Inc. (CSE:NF OTCQX:NFUNF) (“Nuclear Fuels” or the “Company”) today announced that due to strong institutional investor demand, it has entered into an agreement with PI Financial Corp., as sole bookrunner, (“Bookrunner”) along with PowerOne Capital Markets Limited as co-leads, (“PowerOne”, together with PI Financial, the “Underwriters”) to increase the size of the previously announced bought deal private placement from C$5.0 million to C$6.4 million (the “Offering”). Pursuant to the amended terms, the Offering will consist of 10,600,000 units (the “Units”) of the Company at a price of C$0.60 per Unit for gross proceeds of approximately C$6.4 million. Each Unit shall consist of one common...

Continue reading

HilleVax to Present at the 42nd Annual J.P. Morgan Healthcare Conference

HilleVax to Present at the 42nd Annual J.P. Morgan Healthcare Conference

BOSTON, Jan. 03, 2024 (GLOBE NEWSWIRE) — HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced that it will present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, California on Monday, January 8, 2024 at 4:30 p.m. EST / 1:30 p.m. PST. HIL-214, HilleVax’s investigational virus-like particle (VLP) based vaccine for the prevention of moderate-to-severe norovirus-related acute gastroenteritis, and the related ongoing Phase 2b study NEST-IN1 will be topics of discussion. Presentation details:   Date: Monday, January 8, 2024 Time: 1:30 – 2:10 p.m. Pacific Standard Time (PST) Moderator: Eric Joseph, Ph.D. Location: Elizabethan C Room, Westin St. Francis Hotel, San Francisco HilleVax Participant: Robert Hershberg,...

Continue reading

Big Sky Medical Acquires First Asset in Phoenix

Big Sky Medical Acquires First Asset in Phoenix

Blackhawk Medical Center Big Sky acquires Blackhawk Medical Center in Phoenix, Arizona. DALLAS, Jan. 03, 2024 (GLOBE NEWSWIRE) — Big Sky Medical’s first foray into the vibrant Phoenix, Arizona market represents the acquisition of the Blackhawk Medical Center. This three-building medical and office campus spans over 252,000 rsf and is located in the affluent Deer Valley submarket proximate to the Honor Health Deer Valley Medical Center. Blackhawk I (138,540 rsf), Blackhawk II (84,410 rsf), and Blackhawk III (29,400 rsf) are primed to support the anticipated population surge by retaining top notch medical services to fit the growing needs of the community. Each building’s tall ceilings, ample parking, and close hospital proximity make this property prime for future healthcare tenancy. Blackhawk Medical Center is located approximately...

Continue reading

<div>Maui Land & Pineapple Company appoints new board members to support next chapter of growth</div>

Maui Land & Pineapple Company appoints new board members to support next chapter of growth

Accomplished Hawai‘i business leaders, Catherine Ngo and Ken Ota appointed as Independent Directors Catherine Ngo Catherine Ngo Ken Ota Ken Ota MAUI, Hawaii, Jan. 03, 2024 (GLOBE NEWSWIRE) — Maui Land & Pineapple Company, Inc. (NYSE: MLP) announced the appointment of two new Independent Directors to its Board, effective January 1, 2024: Catherine Ngo, a seasoned leader at the intersection of finance, technology, and law; and Maui native Ken Ota, a successful local entrepreneur with over 30 years of experience in the construction industry and water infrastructure. “Catherine and Ken embody esteemed leadership and we are honored to add them to our diverse slate of Directors. We look forward to their thoughtful guidance as we chart the course for a future of growth,” said Race Randle, CEO of Maui Land & Pineapple...

Continue reading

Algoma Steel Provides Fiscal Third Quarter 2024 Guidance

Algoma Steel Provides Fiscal Third Quarter 2024 Guidance

SAULT STE. MARIE, Ontario, Jan. 03, 2024 (GLOBE NEWSWIRE) — Algoma Steel Group Inc. (NASDAQ: ASTL; TSX: ASTL) (“Algoma” or “the Company”), a leading Canadian producer of hot and cold rolled steel sheet and plate products, today provided guidance for its fiscal third quarter ending December 31, 2023. Unless otherwise specified, all amounts are in Canadian dollars. Fiscal 2024 third quarter total steel shipments are expected to be around 515,000 tons and Adjusted EBITDA is expected to be in the range of $(10) million to breakeven. Michael Garcia, Algoma’s Chief Executive Officer commented, “Our operations ran in line with our expectations during the fiscal third quarter, with a heavy focus on seasonal maintenance that included completion of our annual basic oxygen furnace relining and other servicing across the steelworks. Due to...

Continue reading

Razor Energy Corp. Confirms Continued Production Impact

Razor Energy Corp. Confirms Continued Production Impact

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW. CALGARY, Alberta, Jan. 03, 2024 (GLOBE NEWSWIRE) — Razor Energy Corp. (“Razor”) (TSXV: RZE) advises that, as a result of ongoing disputes with the operator of the Judy Creek Gas Plant, the operator continues to restrict access and will not process Razor’s Swan Hills natural gas production. As indicated in Razor’s press release on December 27, 2023, effective December 24th, 2023, a significant portion of Razor’s production was shut-in indefinitely. Management continues to estimate that approximately 1,110 boepd, including 626 bblpd of light oil and 387 bblpd of natural gas liquids, has been curtailed. Razor is exploring various commercial and legal options...

Continue reading

Business First Bancshares, Inc. Announces Fourth Quarter 2023 Earnings Release Date and Conference Call

Business First Bancshares, Inc. Announces Fourth Quarter 2023 Earnings Release Date and Conference Call

BATON ROUGE, La., Jan. 03, 2024 (GLOBE NEWSWIRE) — Business First Bancshares, Inc. (Nasdaq: BFST) (Business First), the parent company of b1BANK, today announced that it is scheduled to release fourth quarter 2023 earnings after market close on Tuesday, January 23, 2024. Executive management will host a conference call and webcast to discuss results on the same day (Tuesday, January 23, 2024) at 4:30 p.m. CDT. Interested parties may attend the call by dialing toll-free 1-800-715-9871 (North America only), conference ID 4061156, or asking for the Business First Bancshares conference call. The live webcast can be found at https://edge.media-server.com/mmc/p/gctma4g8. On the day of the presentation, the corresponding slide presentation will be available to view on the b1BANK website at https://www.b1bank.com/shareholder-info. About...

Continue reading

Banxa Reports Q1 FY24 Financial Results

Banxa Reports Q1 FY24 Financial Results

TORONTO and MELBOURNE, Australia, Jan. 03, 2024 (GLOBE NEWSWIRE) — Banxa Holdings Inc. (TSXV: BNXA) (OTCQX: BNXAF) (FSE: AC00) (“Banxa” or the “Company“) is pleased to report the unaudited first quarter fiscal year 2024 ended September 30th, 2023 (“Q1”) financial results. The full results including Management Discussion & Analysis (“MD&A”) are available on Sedar. Q1 FINANCIAL HIGHLIGHTS(All comparisons are relative to the three-month period ended September 30th, 2022 unless otherwise stated) 68% increase in Total Transaction Volume (“TTV”) to AUD $202 million (USD $136 million), up from AUD $120 million (USD $81 million), driven by growth in the partner base 136% increase in Gross Profit to AUD $6.6 million (USD $4.4 million), up from AUD $2.8 million (USD $1.9 million) due to growth in TTV and...

Continue reading

Comstock Inc. Publishes its 4Q23 Stakeholder Perception Analysis Report

Comstock Inc. Publishes its 4Q23 Stakeholder Perception Analysis Report

VIRGINIA CITY, Nev., Jan. 03, 2024 (GLOBE NEWSWIRE) — Comstock Inc. (NYSE: LODE) (“Comstock” and the “Company”) announces the Company’s fourth quarter 2023 Stakeholder Perception Analysis Report (the “Report”) which was compiled by Comstock’s investor relations firm, RB Milestone Group LLC (“RBMG”), and provides insight into Comstock’s operational milestones and stakeholder perceived strengths and weaknesses. The Report also includes a brief video recording of Comstock’s Executive Chairman and Chief Executive Officer, Corrado De Gasperis, and RBMG’s Managing Director, Trevor Brucato, reviewing and discussing the results. Click Here for Comstock’s 4Q23 Stakeholder Perception Analysis Report RBMG gathered the data from the investor survey during the period of October 26, 2023 (Comstock’s 3Q23 earnings call) to December 31, 2023 (the...

Continue reading

Hepion Pharmaceuticals to Present at NASH-TAG 2024

Hepion Pharmaceuticals to Present at NASH-TAG 2024

EDISON, N.J., Jan. 03, 2024 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeutic drug development for the treatment of non-alcoholic steatohepatitis (“NASH”), fibrotic diseases, hepatocellular carcinoma (“HCC”), and other chronic diseases, today announced that an abstract highlighting its lead drug candidate, rencofilstat, will be presented at the 2024 NASH-TAG Conference, which is being held January 4-6, 2024, in Park City, Utah. Presentation Details Title: Hepatic Functional Improvement Detected by HepQuant DuO within 120 Days of Treatment with Rencofilstat in MASH Subjects with ≥F3 Fibrosis. Authors: SA Harrison, P Mayo, T Hobbs, C Zhao, C Canizares, R Foster, MP McRae, SM Helmke, and GT Everson Date: Saturday, January...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.